Literature DB >> 27564459

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib.

M K Angelopoulou1, J V Asimakopoulos1, Z Galani1, G Levidou2, M Roumelioti3, T P Vassilakopoulos1, P Korkolopoulou2, P Panayiotidis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27564459      PMCID： PMC5022179          DOI： 10.1038/bcj.2016.66

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  14 in total

1.  Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.

Authors:  A Barlow; M Robertson; A Doig; W Stewart; M W Drummond
Journal:  Br J Haematol       Date:  2008-05-15       Impact factor: 6.998

2.  Isolated central nervous system blast crisis in chronic myeloid leukemia.

Authors:  Senthil Rajappa; Shantveer G Uppin; D Raghunadharao; I Satish Rao; Anjna Surath
Journal:  Hematol Oncol       Date:  2004-12       Impact factor: 5.271

3.  A case of isolated lymphoblastic relapse of the central nervous system in a patient with chronic myelogenous leukemia treated with imatinib.

Authors:  Mi-Jung Park; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ja-Young Seo; Ji-Hun Jeong; Moon Jin Kim; Jin-Woo Jeong; Jeong-Yeal Ahn; Jinny Park
Journal:  Ann Lab Med       Date:  2014-04-08       Impact factor: 3.464

4.  Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.

Authors:  Adisak Tantiworawit; Maryse M Power; Michael J Barnett; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Yasser R Abou-Mourad; Sujaatha Narayanan; Raewyn C Broady; Donna L Forrest
Journal:  Leuk Lymphoma       Date:  2012-03-05

5.  Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate.

Authors:  Elias Jabbour; Hagop Kantarjian; Susan O'Brien; Mary Beth Rios; Lynne Abruzzo; Srdan Verstovsek; Guillermo Garcia-Manero; Jorge Cortes
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

6.  Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.

Authors:  Mitsuhiro Matsuda; Yasuyoshi Morita; Takahiro Shimada; Junichi Miyatake; Chikara Hirase; Miyako Tanaka; Yoichi Tatsumi; Yasuhiro Maeda; Akihisa Kanamaru
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

7.  Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.

Authors:  Hagop M Kantarjian; Andreas Hochhaus; Giuseppe Saglio; Carmino De Souza; Ian W Flinn; Leif Stenke; Yeow-Tee Goh; Gianantonio Rosti; Hirohisa Nakamae; Neil J Gallagher; Albert Hoenekopp; Rick E Blakesley; Richard A Larson; Timothy P Hughes
Journal:  Lancet Oncol       Date:  2011-08-17       Impact factor: 41.316

Review 8.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors:  Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

9.  Isolated central nervous system relapse in chronic myeloid leukemia.

Authors:  Juliana Gomez; Victor Duenas
Journal:  Case Rep Med       Date:  2015-03-23

10.  Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature.

Authors:  Rohit Gulati; Yaser Alkhatib; Vijayalakshmi Donthireddy; Michelle Madden Felicella; Madhu P Menon; Kedar V Inamdar
Journal:  Case Rep Pathol       Date:  2015-12-24
View more
  1 in total

1.  Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.

Authors:  Yosuke Okada; Ken Sato; Shinichi Kobayashi; Shigeki Nagao; Kosuke Takano; Masahiro Teramoto; Noriaki Tachi; Toshikuni Kawamura; Toshikatsu Horiuchi; Shoichiro Kato; Reina Saga; Takaaki Maekawa; Takeshi Yamamura; Junichi Watanabe; Ayako Kobayashi; Fumihiko Kimura
Journal:  Int J Hematol       Date:  2017-10-14       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.